» Articles » PMID: 30321294

Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium Tuberculosis in China

Overview
Journal Clin Infect Dis
Date 2018 Oct 16
PMID 30321294
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The increase in multidrug-resistant tuberculosis (MDR-TB) severely hampers tuberculosis prevention and control in China, a country with the second highest MDR-TB burden globally. The first nationwide drug-resistant tuberculosis surveillance program provides an opportunity to comprehensively investigate the epidemiological/drug-resistance characteristics, potential drug-resistance mutations, and effective population changes of Chinese MDR-TB.

Methods: We sequenced 357 MDR strains from 4600 representative tuberculosis-positive sputum samples collected during the survey (70 counties in 31 provinces). Drug-susceptibility testing was performed using 18 anti-tuberculosis drugs, representing the most comprehensive drug-resistance profile to date. We used 3 statistical and 1 machine-learning methods to identify drug-resistance genes/single-nucleotide polymorphisms (SNPs). We used Bayesian skyline analysis to investigate changes in effective population size.

Results: Epidemiological/drug-resistance characteristics showed different MDR profiles, co-resistance patterns, preferred drug combination/use, and recommended regimens among 7 Chinese administrative regions. These factors not only reflected the serious multidrug co-resistance and drug misuse but they were also potentially significant in facilitating the development of appropriate regimens for MDR-TB treatment in China. Further investigation identified 86 drug-resistance genes/intergenic regions/SNPs (58 new), providing potential targets for MDR-TB diagnosis and treatment. In addition, the effective population of Chinese MDR-TB displayed a strong expansion during 1993-2000, reflecting socioeconomic transition within the country. The phenomenon of expansion was restrained after 2000, likely attributable to the advances in diagnosis/treatment technologies and government support.

Conclusions: Our findings provide an important reference and improved understanding of MDR-TB in China, which are potentially significant in achieving the goal of precision medicine with respect to MDR-TB prevention and treatment.

Citing Articles

Association between toxin-antitoxin system mutations and global transmission of MDR-TB.

Li Y, Shao Y, Li Y, Kong X, Tao N, Hou Y BMC Infect Dis. 2024; 24(1):1250.

PMID: 39501228 PMC: 11539496. DOI: 10.1186/s12879-024-10142-4.


A Profile of Drug-Resistant Mutations in Isolates from Guangdong Province, China.

Zhang C, Wu Z, Huang X, Zhao Y, Sun Q, Chen Y Indian J Microbiol. 2024; 64(3):1044-1056.

PMID: 39282200 PMC: 11399372. DOI: 10.1007/s12088-024-01236-3.


Association of mutations in Mycobacterium tuberculosis complex (MTBC) respiration chain genes with hyper-transmission.

Li Y, Li Y, Liu Y, Kong X, Tao N, Hou Y BMC Genomics. 2024; 25(1):810.

PMID: 39198760 PMC: 11350932. DOI: 10.1186/s12864-024-10726-z.


Toxin-antitoxin system gene mutations driving transmission revealed by whole genome sequencing.

Hou Y, Li Y, Tao N, Kong X, Li Y, Liu Y Front Microbiol. 2024; 15:1398886.

PMID: 39144214 PMC: 11322068. DOI: 10.3389/fmicb.2024.1398886.


Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India.

Dixit A, Ektefaie Y, Kagal A, Freschi L, Karyakarte R, Lokhande R J Infect Dis. 2024; 231(1):84-93.

PMID: 38819323 PMC: 11793027. DOI: 10.1093/infdis/jiae240.


References
1.
Mao T, Okada K, Yamada N, Peou S, Ota M, Saint S . Cross-sectional studies of tuberculosis prevalence in Cambodia between 2002 and 2011. Bull World Health Organ. 2014; 92(8):573-81. PMC: 4147411. DOI: 10.2471/BLT.13.131581. View

2.
Desjardins C, Cohen K, Munsamy V, Abeel T, Maharaj K, Walker B . Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance. Nat Genet. 2016; 48(5):544-51. PMC: 4848111. DOI: 10.1038/ng.3548. View

3.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

4.
Bi P, Tong S, Parton K . Family self-medication and antibiotics abuse for children and juveniles in a Chinese city. Soc Sci Med. 2000; 50(10):1445-50. DOI: 10.1016/s0277-9536(99)00304-4. View

5.
Casali N, Nikolayevskyy V, Balabanova Y, Harris S, Ignatyeva O, Kontsevaya I . Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet. 2014; 46(3):279-86. PMC: 3939361. DOI: 10.1038/ng.2878. View